Picture of SymBio Pharmaceuticals logo

4582 — SymBio Pharmaceuticals News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: SymBio Pharmaceuticals -2016 parent results

Feb 9 (Reuters)-  
          SymBio Pharmaceuticals Limited  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended        Year to        NEXT    
              Dec 31, 2016    Dec 31, 2015    Dec 31, 2017      YEAR      
                 LATEST         YEAR-AGO         COMPANY       COMPANY    
                 RESULTS         RESULTS        FORECAST     H1 FORECAST  
  Sales           2.37            1.93            2.90                    
               (+22.5 pct)     (-1.1 pct)      (+22.6 pct)                
  Operating     loss 2.13       loss 2.55       loss 3.24                 
  Recurring     loss 2.32       loss 2.63       loss 3.30                 
  Net           loss 2.31       loss 2.63       loss 3.31                 
  EPS        loss 58.82 yen  loss 81.26 yen  loss 71.07 yen               
  Ann Div          NIL             NIL             NIL                    
  -Q2 Div          NIL             NIL             NIL                    
  -Q4 Div          NIL             NIL             NIL                    
   
  NOTE - SymBio Pharmaceuticals Limited.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on SymBio Pharmaceuticals

See all news